PURPOSE: As a diet rich in fructose and an impaired intestinal barrier function have been proposed to be risk factors for the development of non-alcoholic fatty liver disease (NAFLD), the aim of the present pilot study was to determine whether a dietary intervention focusing on a reduction of fructose intake (-50 % in comparison with baseline) has a beneficial effect on liver status. METHODS: A total of 15 patients with NAFLD were enrolled in the study of which 10 finished the study. Fructose and total nutrient intake were assessed using a diet history. At baseline and after 6 months liver status and markers of intestinal barrier function as well as plasminogen activator inhibitor (PAI-) 1 concentration were determined in plasma. RESULTS: Hepatic lipid content and transaminases in plasma as well as body mass index and some parameters of glucose metabolism (e.g., fasting plasma insulin) were significantly lower at the end of the intervention when compared to baseline. Whereas the dietary intervention had no effect on the prevalence of bacterial overgrowth, orocecal transit time and the intestinal permeability or blood ethanol levels endotoxin and PAI-1 concentration in plasma were significantly lower at the end of 6 months intervention period than at baseline. CONCLUSIONS: Taken together, our results indicate that a dietary intervention focusing only on one dietary parameter like fructose may help to decrease intrahepatic fat content of NAFLD patients.
PURPOSE: As a diet rich in fructose and an impaired intestinal barrier function have been proposed to be risk factors for the development of non-alcoholic fatty liver disease (NAFLD), the aim of the present pilot study was to determine whether a dietary intervention focusing on a reduction of fructose intake (-50 % in comparison with baseline) has a beneficial effect on liver status. METHODS: A total of 15 patients with NAFLD were enrolled in the study of which 10 finished the study. Fructose and total nutrient intake were assessed using a diet history. At baseline and after 6 months liver status and markers of intestinal barrier function as well as plasminogen activator inhibitor (PAI-) 1 concentration were determined in plasma. RESULTS: Hepatic lipid content and transaminases in plasma as well as body mass index and some parameters of glucose metabolism (e.g., fasting plasma insulin) were significantly lower at the end of the intervention when compared to baseline. Whereas the dietary intervention had no effect on the prevalence of bacterial overgrowth, orocecal transit time and the intestinal permeability or blood ethanol levels endotoxin and PAI-1 concentration in plasma were significantly lower at the end of 6 months intervention period than at baseline. CONCLUSIONS: Taken together, our results indicate that a dietary intervention focusing only on one dietary parameter like fructose may help to decrease intrahepatic fat content of NAFLD patients.
Authors: Giridhar Kanuri; Astrid Spruss; Sabine Wagnerberger; Stephan C Bischoff; Ina Bergheim Journal: Lab Invest Date: 2011-03-21 Impact factor: 5.662
Authors: Alejandro Soza; Arnoldo Riquelme; Robinson González; Manuel Alvarez; Rosa María Pérez-Ayuso; Juan Carlos Glasinovic; Marco Arrese Journal: Dig Dis Sci Date: 2005-06 Impact factor: 3.199
Authors: Luca Miele; Venanzio Valenza; Giuseppe La Torre; Massimo Montalto; Giovanni Cammarota; Riccardo Ricci; Roberta Mascianà; Alessandra Forgione; Maria L Gabrieli; Germano Perotti; Fabio M Vecchio; Gianlodovico Rapaccini; Giovanni Gasbarrini; Chris P Day; Antonio Grieco Journal: Hepatology Date: 2009-06 Impact factor: 17.425
Authors: Ashkan Farhadi; Sushama Gundlapalli; Maliha Shaikh; Constantine Frantzides; Laura Harrell; Mary M Kwasny; Ali Keshavarzian Journal: Liver Int Date: 2008-04-07 Impact factor: 5.828
Authors: Giulia Paolella; Claudia Mandato; Luca Pierri; Marco Poeta; Martina Di Stasi; Pietro Vajro Journal: World J Gastroenterol Date: 2014-11-14 Impact factor: 5.742
Authors: Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff Journal: Clin Nutr Date: 2019-01-16 Impact factor: 7.324
Authors: Jiantao Ma; Micaela C Karlsen; Mei Chung; Paul F Jacques; Edward Saltzman; Caren E Smith; Caroline S Fox; Nicola M McKeown Journal: Nutr Rev Date: 2015-10-29 Impact factor: 7.110
Authors: M Angeles Zulet; Itziar Abete; Cristina Galarregui; Irene Cantero; Bertha Araceli Marin-Alejandre; J Ignacio Monreal; Mariana Elorz; Alberto Benito-Boillos; José Ignacio Herrero; Víctor de la O; Miguel Ruiz-Canela; Helen Hermana M Hermsdorff; Josefina Bressan; Josep A Tur; J Alfredo Martínez Journal: Eur J Nutr Date: 2020-08-28 Impact factor: 5.614
Authors: Silvia Marinho Ferolla; Luciana Costa Silva; Maria de Lourdes Abreu Ferrari; Aloísio Sales da Cunha; Flaviano Dos Santos Martins; Cláudia Alves Couto; Teresa Cristina Abreu Ferrari Journal: World J Hepatol Date: 2015-10-28